Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia.

@article{Giganti2012SixmonthHC,
  title={Six-month hemoglobin concentration and its association with subsequent mortality among adults on antiretroviral therapy in Lusaka, Zambia.},
  author={Mark Joseph Giganti and Mohammed I Limbada and Albert J. Mwango and Crispin Moyo and Lloyd B. Mulenga and M Brad Guffey and Priscilla L. Mulenga and Carolyn Bolton-Moore and Jeffrey S. A. Stringer and Benjamin H Chi},
  journal={Journal of acquired immune deficiency syndromes},
  year={2012},
  volume={61 1},
  pages={120-3}
}
Little is known about changes in hemoglobin concentration early in the course of antiretroviral therapy and its subsequent relation to survival. We analyzed data for 40,410 HIV-infected adults on antiretroviral therapy in Lusaka, Zambia. Our main exposure of interest was 6-month hemoglobin, but we stratified our analysis by baseline hemoglobin to allow for potential effect modification. Patients with a 6-month hemoglobin <8.5 g/dL, regardless of baseline, had the highest hazard for death after… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 1 time over the past 90 days. VIEW TWEETS